Dihydrocodeine Ennogen Ip Ltd

Dihydrocodeine Tartrate is an opioid pain reliever used for moderate to severe pain management. This oral medication is manufactured by Ennogen IP Limited and is available in various strengths.

Dihydrocodeine Tartrate is commonly used for pain relief, particularly in cases of moderate to severe pain. It works by binding to opioid receptors in the brain and spinal cord, which can help alleviate discomfort. This medication is often prescribed for conditions that require strong pain management, such as post-surgical pain or chronic pain conditions.

Common effects of Dihydrocodeine Tartrate may include drowsiness, dizziness, and nausea. Some users might experience constipation or dry mouth. These effects can vary depending on the individual and the dosage. It is important to monitor how your body responds to the medication and consult a healthcare provider if any effects are concerning.

Dihydrocodeine Tartrate should be handled with care. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication can cause drowsiness, so it is advisable to avoid driving or operating heavy machinery until you know how it affects you. Always store the medication in a safe place, out of reach of children and pets.

Dihydrocodeine Tartrate may interact with other medications, including alcohol, sedatives, and certain antidepressants. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Combining this medication with alcohol or other central nervous system depressants can increase the risk of severe side effects.